Biblio

Export 309 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Keyword is T  [Clear All Filters]
2024
A. Mahzarnia, Lutz, M. W., and Badea, A., “A Continuous Extension of Gene Set Enrichment Analysis Using the Likelihood Ratio Test Statistics Identifies Vascular Endothelial Growth Factor as a Candidate Pathway for Alzheimer's Disease via ITGA5.”, J Alzheimers Dis, vol. 97, no. 2, pp. 635-648, 2024.
K. Kumar Soli Sai, Erichsen, J. M., Gollapelli, K. K., Krizan, I., Miller, M., Bansode, A., Jorgensen, M. J., Register, T., Cazzola, C., Gandhi, R., Suman, J., and Craft, S., “First Biodistribution Study of [68Ga]Ga-NOTA-Insulin Following Intranasal Administration in Adult Vervet Monkeys.”, J Alzheimers Dis, vol. 101, no. 1, pp. 309-320, 2024.
I. Frentz, van Arendonk, J., Leeuwis, A. E., Vernooij, M. W., van der Flier, W. M., Bos, D., De Deyn, P. Paul, Wolters, F. J., and M Ikram, A., “Interaction Between Arteriosclerosis and Amyloid-β on Cognitive Function.”, J Alzheimers Dis, vol. 97, no. 2, pp. 953-961, 2024.
K. Ishii, Yamada, T., Hanaoka, K., Kaida, H., Kojita, Y., Kono, A., Hanada, K., Saigoh, K., Sakuta, S., Hashimoto, M., Kato, T., and Nakamura, A., “Regional differences in glucose metabolic decline and tau deposition in the Alzheimer's continuum brain.”, J Alzheimers Dis, vol. 102, no. 1, pp. 228-236, 2024.
C. Marr, McDowell, B., Holmes, C., Edwards, C. J., Cardwell, C., McHenry, M., Meenagh, G., Teeling, J. L., and McGuinness, B., “The RESIST Study: Examining Cognitive Change in Rheumatoid Arthritis Patients with Mild Cognitive Impairment Being Treated with a TNF-Inhibitor Compared to a Conventional Synthetic Disease-Modifying Anti-Rheumatic Drug.”, J Alzheimers Dis, vol. 99, no. 1, pp. 161-175, 2024.
C. Marr, McDowell, B., Holmes, C., Edwards, C. J., Cardwell, C., McHenry, M., Meenagh, G., Teeling, J. L., and McGuinness, B., “The RESIST Study: Examining Cognitive Change in Rheumatoid Arthritis Patients with Mild Cognitive Impairment Being Treated with a TNF-Inhibitor Compared to a Conventional Synthetic Disease-Modifying Anti-Rheumatic Drug.”, J Alzheimers Dis, vol. 99, no. 1, pp. 161-175, 2024.
2023
N. Ortí-Casañ, Wajant, H., H Kuiperij, B., Hooijsma, A., Tromp, L., Poortman, I. L., Tadema, N., de Lange, J. H. E., Verbeek, M. M., De Deyn, P. P., Naudé, P. J. W., and Eisel, U. L. M., “Activation of TNF Receptor 2 Improves Synaptic Plasticity and Enhances Amyloid-β Clearance in an Alzheimer's Disease Mouse Model with Humanized TNF Receptor 2.”, J Alzheimers Dis, vol. 94, no. 3, pp. 977-991, 2023.
D. L. Alkon, Sun, M. - K., Tuchman, A. J., and Thompson, R. E., “Advanced Alzheimer's Disease Patients Show Safe, Significant, and Persistent Benefit in 6-Month Bryostatin Trial.”, J Alzheimers Dis, vol. 96, no. 2, pp. 759-766, 2023.
C. Grobler, van Tongeren, M., Gettemans, J., Kell, D. B., and Pretorius, E., “Alzheimer's Disease: A Systems View Provides a Unifying Explanation of Its Development.”, J Alzheimers Dis, vol. 91, no. 1, pp. 43-70, 2023.
C. Gonzalez, Mimmack, K. J., Amariglio, R. E., J Becker, A., Chhatwal, J. P., Fitzpatrick, C. D., Gatchel, J. R., Johnson, K. A., Katz, Z. S., Kuppe, M. K., Locascio, J. J., Udeogu, O. J., Papp, K. V., Premnath, P., Properzi, M. J., Rentz, D. M., Schultz, A. P., Sperling, R. A., Vannini, P., Wang, S., and Marshall, G. A., “Associations of the Harvard Automated Phone Task and Alzheimer's Disease Pathology in Cognitively Normal Older Adults: Preliminary Findings.”, J Alzheimers Dis, vol. 94, no. 1, pp. 217-226, 2023.
C. Giuseppina Bonomi, Assogna, M., Di Donna, M. Gaia, Bernocchi, F., De Lucia, V., Nuccetelli, M., Fiorelli, D., Loizzo, S., Mercuri, N. Biagio, Koch, G., Martorana, A., and Motta, C., “Cerebrospinal Fluid sTREM-2, GFAP, and β-S100 in Symptomatic Sporadic Alzheimer's Disease: Microglial, Astrocytic, and APOE Contributions Along the Alzheimer's Disease Continuum.”, J Alzheimers Dis, vol. 92, no. 4, pp. 1385-1397, 2023.
A. - M. C. Leiby, Scambray, K. A., Nguyen, H. L., Basith, F., Fakhraee, S., Melikyan, Z. A., Bukhari, S. A., Montine, T. J., Corrada, M. M., Kawas, C. H., and S Sajjadi, A., “Characterizing Limbic-Predominant Age-Related TDP-43 Encephalopathy Without Alzheimer's Disease and Lewy Body Dementia in the Oldest Old: A Case Series.”, J Alzheimers Dis, vol. 96, no. 1, pp. 113-124, 2023.
A. - M. C. Leiby, Scambray, K. A., Nguyen, H. L., Basith, F., Fakhraee, S., Melikyan, Z. A., Bukhari, S. A., Montine, T. J., Corrada, M. M., Kawas, C. H., and S Sajjadi, A., “Characterizing Limbic-Predominant Age-Related TDP-43 Encephalopathy Without Alzheimer's Disease and Lewy Body Dementia in the Oldest Old: A Case Series.”, J Alzheimers Dis, vol. 96, no. 1, pp. 113-124, 2023.
M. Liu, Li, M., He, J., He, Y., Yang, J., and Sun, Z., “Chiral Amino Acid Profiling in Serum Reveals Potential Biomarkers for Alzheimer's Disease.”, J Alzheimers Dis, vol. 94, no. 1, pp. 291-301, 2023.
J. M. Walker, Gonzales, M. M., Goette, W., Farrell, K., Iii, C. L. White, Crary, J. F., and Richardson, T. E., “Cognitive and Neuropsychological Profiles in Alzheimer's Disease and Primary Age-Related Tauopathy and the Influence of Comorbid Neuropathologies.”, J Alzheimers Dis, vol. 92, no. 3, pp. 1037-1049, 2023.
A. Boulares, Fabre, C., Cherni, A., Jdidi, H., Chortane, S. Gaied, Trompetto, C., Puce, L., and Bragazzi, N. Luigi, “Effects of a Physical Activity Program that Incorporates Exercises Targeting Balance, Strength, and Proprioception on Cognitive Functions and Physical Performance in Old Adults with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 96, no. 1, pp. 245-260, 2023.
K. Rajah Kumaran, Yunusa, S., Perimal, E., Wahab, H., Müller, C. P., and Hassan, Z., “Insights into the Pathophysiology of Alzheimer's Disease and Potential Therapeutic Targets: A Current Perspective.”, J Alzheimers Dis, vol. 91, no. 2, pp. 507-530, 2023.
A. L. Wiseman, Briggs, C. A., Peritt, A., Kapecki, N., Peterson, D. A., Shim, S. S., and Stutzmann, G. E., “Lithium Provides Broad Therapeutic Benefits in an Alzheimer's Disease Mouse Model.”, J Alzheimers Dis, vol. 91, no. 1, pp. 273-290, 2023.
S. M. de la Monte, “Malignant Brain Aging: The Formidable Link Between Dysregulated Signaling Through Mechanistic Target of Rapamycin Pathways and Alzheimer's Disease (Type 3 Diabetes).”, J Alzheimers Dis, vol. 95, no. 4, pp. 1301-1337, 2023.
J. Alexander Jarholm, Bjørnerud, A., Dalaker, T. Olene, Akhavi, M. Sadat, Kirsebom, B. Eivind, Pålhaugen, L., Nordengen, K., Grøntvedt, G. Rolfseng, Nakling, A., Kalheim, L. F., Almdahl, I. S., Tecelao, S., Fladby, T., and Selnes, P., “Medial Temporal Lobe Atrophy in Predementia Alzheimer's Disease: A Longitudinal Multi-Site Study Comparing Staging and A/T/N in a Clinical Research Cohort.”, J Alzheimers Dis, vol. 94, no. 1, pp. 259-279, 2023.
A. P. Gabrielli, Weidling, I., Ranjan, A., Wang, X., Novikova, L., Chowdhury, S. Roy, Menta, B., Berkowicz, A., Wilkins, H. M., Peterson, K. R., and Swerdlow, R. H., “Mitochondria Profoundly Influence Apolipoprotein E Biology.”, J Alzheimers Dis, vol. 92, no. 2, pp. 591-604, 2023.
S. M. Shirgadwar, Kumar, R., Preeti, K., Khatri, D. Kumar, and Singh, S. Bala, “Neuroprotective Effect of Phloretin in Rotenone-Induced Mice Model of Parkinson's Disease: Modulating mTOR-NRF2-p62 Mediated Autophagy-Oxidative Stress Crosstalk.”, J Alzheimers Dis, vol. 94, no. s1, pp. S109-S124, 2023.
H. Sandison, Callan, N. G. L., Rao, R. V., Phipps, J., and Bradley, R., “Observed Improvement in Cognition During a Personalized Lifestyle Intervention in People with Cognitive Decline.”, J Alzheimers Dis, vol. 94, no. 3, pp. 993-1004, 2023.
H. Sandison, Callan, N. G. L., Rao, R. V., Phipps, J., and Bradley, R., “Observed Improvement in Cognition During a Personalized Lifestyle Intervention in People with Cognitive Decline.”, J Alzheimers Dis, vol. 94, no. 3, pp. 993-1004, 2023.
P. Chatterjee, Doré, V., Pedrini, S., Krishnadas, N., Thota, R., Bourgeat, P., Ikonomovic, M. D., Rainey-Smith, S. R., Burnham, S. C., Fowler, C., Taddei, K., Mulligan, R., Ames, D., Masters, C. L., Fripp, J., Rowe, C. C., Martins, R. N., and Villemagne, V. L., “Plasma Glial Fibrillary Acidic Protein Is Associated with 18F-SMBT-1 PET: Two Putative Astrocyte Reactivity Biomarkers for Alzheimer's Disease.”, J Alzheimers Dis, vol. 92, no. 2, pp. 615-628, 2023.

Pages